NAROPIN

Henry Schein, Inc.🇺🇸 United States

FDA Page

Effective Date: Jul 22, 2026
Approval ID: 6a2f1f6d-026f-4f39-aee0-5b75b8eb5c02
Products: 1 registered
Version: 6

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use NAROPIN® safely and effectively. See full prescribing information for NAROPIN®. NAROPIN® (ropivacaine hydrochloride) injection, for epidural, perineural, or infiltration use Initial U.S. Approval: 1996 Rx Only

Quick Stats

Total Products1

Labelers2

Label Sections12

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.